Medicare Enrolled
Dr. Gary Vicik, M.D.
Optician · Belleville, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Vicik from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vicik?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vicik
Dr. Gary Vicik is an optician specialist in Belleville, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Vicik performed 6,707 Medicare services across 2,584 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vicik received a total of $11,962 from 32 pharmaceutical and/or device companies across 613 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vicik is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 8% volume in IL
$11,962 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,707
Medicare services
Top 8% in IL for optician
2,584
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~335 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,378 | $5 | $20 |
| Ultrasound guidance for radiation therapy field placement Use of ultrasound imaging to help position radiation therapy fields accurately during treatment. |
791 | $134 | $270 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
765 | $60 | $110 |
| Radiation treatment planning, 1 area This procedure involves gathering the necessary data to design the most effective radiation therapy plan for a single treatment area. |
727 | $200 | $450 |
| Superficial or low voltage radiation treatment A radiation therapy procedure that delivers radiation to the surface of the body or uses low voltage energy. This treatment targets areas close to the skin. |
704 | $31 | $70 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
457 | $81 | $150 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
360 | $36 | $110 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
262 | $76 | $160 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
235 | $61 | $175 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
144 | $41 | $70 |
| Radiation treatment management, 5 sessions Oversight and management of a radiation therapy course consisting of five treatment sessions. |
136 | $152 | $400 |
| Continuing radiation therapy consultation per week A weekly consultation to review and manage ongoing radiation therapy treatment. |
112 | $65 | $125 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
104 | $54 | $150 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
74 | $1 | $10 |
| Destruction of skin growth, 15 or more growths | 68 | $86 | $190 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
61 | $9 | $40 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
55 | $120 | $300 |
| Calculation of radiation therapy dose | 52 | $51 | $125 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
51 | $37 | $100 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
29 | $78 | $215 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
28 | $36 | $100 |
| Simple radiation therapy planning This procedure involves the initial planning phase for radiation therapy treatment. It includes the setup and configuration required to prepare for delivering radiation to a specific area. |
24 | $56 | $125 |
| Design and construction of simple radiation treatment device This code covers the design and construction of a simple radiation treatment device. It does not specify the clinical purpose or condition being treated. |
21 | $30 | $200 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters. |
19 | $92 | $210 |
| Destruction of cancerous skin growth on face, 1.1-2.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 1.1 and 2.0 centimeters in diameter. |
18 | $144 | $290 |
| Destruction of cancerous skin growth on face, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin lesion located on the face, ears, eyelids, nose, lips, or mouth. The lesion treated measures between 0.6 and 1.0 centimeters in diameter. |
17 | $123 | $250 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
15 | $221 | $440 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,962
Total received (2018-2024)
Avg $1,709/year across 7 years
Top 8% in IL for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
613
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,484 (96.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$478 (4.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,645
2023
$1,501
2022
$1,805
2021
$1,130
2020
$1,112
2019
$2,343
2018
$2,427
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$469
E.R. Squibb & Sons, L.L.C.
$205
Janssen Biotech, Inc.
$176
Amgen Inc.
$134
LEO Pharma Inc.
$122
Incyte Corporation
$104
Novartis Pharmaceuticals Corporation
$94
Regeneron Healthcare Solutions, Inc.
$85
Arcutis Biotherapeutics, Inc.
$83
Lilly USA, LLC
$79
UCB, Inc.
$57
Galderma Laboratories, L.P.
$20
GENZYME CORPORATION
$17
Top 3 companies account for 51.7% of 2024 payments
All-time payments by company (2018-2024) ›
Merz North America, Inc.
$1,710
ABBVIE INC.
$1,252
Janssen Biotech, Inc.
$1,045
AbbVie Inc.
$1,017
AbbVie, Inc.
$724
Celgene Corporation
$630
Lilly USA, LLC
$609
Amgen Inc.
$569
Regeneron Healthcare Solutions, Inc.
$411
UCB, Inc.
$408
LEO Pharma Inc.
$392
PFIZER INC.
$388
Incyte Corporation
$381
E.R. Squibb & Sons, L.L.C.
$365
Novartis Pharmaceuticals Corporation
$355
GENZYME CORPORATION
$283
Dermavant Sciences, Inc.
$194
Galderma Laboratories, L.P.
$180
Sun Pharmaceutical Industries Inc.
$150
MAYNE PHARMA INC.
$144
Mayne Pharma Inc.
$143
Arcutis Biotherapeutics, Inc.
$113
SUN PHARMACEUTICAL INDUSTRIES INC.
$104
MERZ NORTH AMERICA, INC.
$85
SANOFI-AVENTIS U.S. LLC
$72
DERMIRA, INC.
$65
NOVARTIS PHARMACEUTICALS CORPORATION
$62
Taro Pharmaceuticals USA, Inc.
$42
Genentech USA, Inc.
$25
Biofrontera Inc.
$16
Almirall LLC
$15
Ortho Dermatologics, a division of Bausch Health US, LLC
$14
Top 3 companies account for 33.5% of all-time payments
Associated products mentioned in payments ›
ABSORICA (isotretinoin) · ADBRY · AKLIEF · AMELUZ · BLU-U · Bimzelx · CIBINQO · COSENTYX · Cimzia · DORYX · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EBGLYSS · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Erivedge · FABIOR · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · LIBTAYO · ODOMZO · OLUMIANT · OPZELURA · ORACEA · Otezla · PICATO · QBREXZA · REMICADE · RINVOQ · SILIQ · SKYRIZI · Seysara · Skyrizi · Sotyktu · TALTZ · TREMFYA · Tremfya · ULTRAVATE (halobetasol propionate) lotion · USP) 0.1% · VTAMA · XELJANZ · XEOMIN · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for optician in IL.
Geographic Context
Opticians within 10 mi
157
Per 100K population
61.6
County median income
$70,178
Nearest hospital
MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Vicik is a clinical cardiology specialist, with above-average Medicare volume (top 8% in IL), with low-engagement industry engagement in the top 8% of IL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Vicik experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Vicik performed 1,378 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vicik receive payments from pharmaceutical companies?
Yes. Dr. Vicik received a total of $11,962 from 32 companies across 613 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vicik's costs compare to other opticians in Belleville?
Dr. Vicik's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vicik) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Belleville
Browse opticians in Belleville ranked by procedure volume and transparency data.
Highest volume
Top Opticians in IL
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in IL
Which IL opticians receive the most from drug and device companies.
By company
Merz North America, Inc. Payments to Doctors
See all physicians who received payments from Merz North America, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology